Oppenheimer Asset Management Inc. reduced its stake in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) by 7.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,520 shares of the medical equipment provider’s stock after selling 1,298 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Smith & Nephew SNATS were worth $540,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of SNN. Bank of Montreal Can increased its stake in Smith & Nephew SNATS by 1.3% during the first quarter. Bank of Montreal Can now owns 23,315 shares of the medical equipment provider’s stock worth $721,000 after acquiring an additional 289 shares during the last quarter. Russell Investments Group Ltd. bought a new stake in Smith & Nephew SNATS during the first quarter worth approximately $2,884,000. Wells Fargo & Company MN increased its stake in Smith & Nephew SNATS by 21.4% during the first quarter. Wells Fargo & Company MN now owns 429,522 shares of the medical equipment provider’s stock worth $13,285,000 after acquiring an additional 75,572 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Smith & Nephew SNATS by 3.9% during the first quarter. Bank of New York Mellon Corp now owns 66,199 shares of the medical equipment provider’s stock worth $2,048,000 after acquiring an additional 2,509 shares during the last quarter. Finally, Comerica Bank increased its stake in Smith & Nephew SNATS by 1.8% during the first quarter. Comerica Bank now owns 32,120 shares of the medical equipment provider’s stock worth $1,064,000 after acquiring an additional 578 shares during the last quarter. 6.36% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Oppenheimer Asset Management Inc. Has $540,000 Holdings in Smith & Nephew SNATS, Inc. (SNN)” was first published by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and international copyright and trademark laws. The original version of this piece of content can be read at https://www.dailypolitical.com/2017/09/15/oppenheimer-asset-management-inc-has-540000-holdings-in-smith-nephew-snats-inc-snn.html.

Shares of Smith & Nephew SNATS, Inc. (NYSE SNN) opened at 36.84 on Friday. The stock has a market cap of $16.13 billion, a price-to-earnings ratio of 18.76 and a beta of 0.75. Smith & Nephew SNATS, Inc. has a one year low of $26.97 and a one year high of $37.22. The company has a 50 day moving average price of $35.84 and a 200-day moving average price of $33.90.

The company also recently declared a semiannual dividend, which will be paid on Wednesday, November 1st. Stockholders of record on Friday, October 6th will be issued a dividend of $0.246 per share. The ex-dividend date is Thursday, October 5th. This represents a dividend yield of 1.37%.

Several research analysts have issued reports on the company. BidaskClub lowered Smith & Nephew SNATS from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Zacks Investment Research upgraded Smith & Nephew SNATS from a “hold” rating to a “buy” rating and set a $40.00 target price for the company in a research report on Wednesday, June 7th. Four research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Smith & Nephew SNATS has an average rating of “Buy” and a consensus target price of $38.00.

Smith & Nephew SNATS Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Institutional Ownership by Quarter for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related companies with MarketBeat.com's FREE daily email newsletter.